The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 778 | 19,951 | SH | SOLE | 0 | 0 | 19,951 | ||
DOCUSIGN INC | COM | 256163106 | 3,435 | 66,253 | SH | SOLE | 0 | 0 | 66,253 | ||
JBG SMITH COM | COM | 46590V100 | 72,768 | 1,759,817 | SH | SOLE | 0 | 0 | 1,759,817 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 1,306 | 47,643 | SH | SOLE | 0 | 0 | 47,643 |